has subject area Angiotensin II Type 1 Receptor Blockers Angiotensin-Converting Enzyme Inhibitors Antihypertensive Agents Blood Pressure Drug Therapy, Combination Humans Hypertension Randomized Controlled Trials as Topic Renin-Angiotensin System Risk Assessment Risk Factors Treatment Outcome